Don't be too Quick to Jump on the Jardiance (empagliflozin) Bandwagon

November 2015

You'll hear cautious optimism about cardiovascular benefits with the SGLT2 inhibitor, Jardiance (empagliflozin).

Until now, metformin seemed to be the only diabetes med linked to a reduction in cardiovascular events in patients with type 2 diabetes.

But new evidence suggests that Jardiance also reduces CV risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Diabetes Don't be too Quick to Jump on the Jardiance (empagliflozin) Bandwagon
Insulin Consider NPH and Regular Insulin INSTEAD of Insulin Analogs
Sinusitis Explain Chronic Sinusitis is Usually Due to Inflammation...Not Infection
Aspirin Narrow Your Use of Aspirin for Primary Prevention
Vaccines Wait at Least One Year Between Pneumococcal Vaccines in Seniors
Practice Check Your PDMP BEFORE Writing a Controlled Med Rx
Chronic Pain Suggest Alternatives for Neuropathic Pain Prior to Using Opioids
Supplements Tell Patients to Forget About Using Prevagen for Memory
Sports Medicine Recommend Baby Oil to Remove Kinesiology Tape
Psychiatry Recertify to Continue Prescribing Clozapine
Pediatrics Explain Why Just One Dose of Tramadol Can be Risky in Children